News

Filter

Current filters:

HerceptinLicensing

Roche signs up to $490 million accord with PTC Thera for SMA program; and deal with Galena

30-11-2011

Swiss drug major Roche (ROG: SIX) has signed a licensing agreement with privately-held US firm PTC Therapeutics…

Galena BioPharmaHerceptinLicensingNeuVaxOncologyPharmaceuticalPTC TherapeuticsRare diseasesResearchRoche

Roche to start production of Herceptin in Russia

23-06-2011

R-Farm, one of Russia’s largest drugs’ distributors, has reached an agreement with Roche (ROG:…

EuropeHerceptinLicensingMarkets & MarketingOncologyPharmaceuticalR-FarmRoche

US FDA approves Genentech/Roche’s Herceptin for HER2-positive metastatic stomach cancer; Roche amends deal with Biogen

22-10-2010

US biotech giant Genentech, part of Swiss drug major Roche (ROG: VX), says the US Food and Drug Administration…

Biogen IdecGenentechHerceptinLicensingNorth AmericaocrelizumabOncologyPharmaceuticalRegulationRoche

COMPANY SPOTLIGHT

Menarini

Back to top